M-NINEVAX®-C
Pharmaceutical Name
Pasteurella multocida Vaccine, Avirulent Live Culture, Avian Isolate
Features and Benefits
Avirulent M-9 strain, Heddleston Type 3 x 4, will not revert to virulence.
Mild reaction.
Unique slow-growing mutant strain.
Strong protection proven in clinical studies and extensive field trials.
Indications
For the vaccination of healthy chickens and turkeys as an aid in the prevention of fowl cholera due to P. multocida. M-NINEVAX-C is a live bacterial vaccine containing the mild avirulent M-9 strain of Pasteurella multocida, Heddleston Type 3-4 cross. This vaccine strain has been show to offer protection against fowl cholera in chickens and turkeys.
Chickens: Use by wing-web stab to vaccinate chickens 10-12 weeks of age and again at 18-20 weeks of age against pasteurellosis (fowl cholera) due to P. multocida Type 1. There should be at least 6 weeks and no more than 10 weeks between vaccinations.
Turkeys: Use by wing-web stab to vaccinate turkey breeders 15 weeks of age or older against pasteurellosis (fowl cholera) due to P. multocida Type 3. Birds should initially be wing-web vaccinated at 15-18 weeks of age and again 8 weeks later. Turkey breeders must be vaccinated at least twice with live fowl cholera vaccine via oral route prior to wing-web vaccination. The interval between the last oral vaccination and the first wing-web vaccination should not exceed 6 weeks. Additional wing-web vaccination every 6-8 weeks throughout the life of the bird may be required in areas of endemic exposure to fowl cholera.
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
M-NINEVAX®-C is a registered trademark of Schering-Plough Animal Health Corporation.
Species

